全文获取类型
收费全文 | 2216篇 |
免费 | 87篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 38篇 |
妇产科学 | 21篇 |
基础医学 | 344篇 |
口腔科学 | 14篇 |
临床医学 | 141篇 |
内科学 | 606篇 |
皮肤病学 | 87篇 |
神经病学 | 212篇 |
特种医学 | 85篇 |
外科学 | 390篇 |
综合类 | 17篇 |
一般理论 | 3篇 |
预防医学 | 122篇 |
眼科学 | 26篇 |
药学 | 94篇 |
肿瘤学 | 86篇 |
出版年
2023年 | 9篇 |
2021年 | 35篇 |
2020年 | 31篇 |
2019年 | 28篇 |
2018年 | 43篇 |
2017年 | 29篇 |
2016年 | 37篇 |
2015年 | 29篇 |
2014年 | 58篇 |
2013年 | 79篇 |
2012年 | 114篇 |
2011年 | 151篇 |
2010年 | 73篇 |
2009年 | 83篇 |
2008年 | 127篇 |
2007年 | 175篇 |
2006年 | 152篇 |
2005年 | 149篇 |
2004年 | 117篇 |
2003年 | 78篇 |
2002年 | 94篇 |
2001年 | 21篇 |
2000年 | 17篇 |
1999年 | 22篇 |
1998年 | 16篇 |
1996年 | 10篇 |
1995年 | 11篇 |
1994年 | 20篇 |
1993年 | 10篇 |
1991年 | 9篇 |
1989年 | 11篇 |
1978年 | 9篇 |
1960年 | 10篇 |
1958年 | 9篇 |
1954年 | 8篇 |
1943年 | 9篇 |
1939年 | 8篇 |
1936年 | 10篇 |
1935年 | 8篇 |
1933年 | 13篇 |
1932年 | 12篇 |
1931年 | 11篇 |
1930年 | 9篇 |
1929年 | 10篇 |
1928年 | 9篇 |
1927年 | 15篇 |
1926年 | 13篇 |
1925年 | 15篇 |
1924年 | 14篇 |
1911年 | 11篇 |
排序方式: 共有2305条查询结果,搜索用时 203 毫秒
81.
Dietmar?A.?JacobEmail author Christine?Schug-Pa? Florian?Sommerer Andrea?Tannapfel Hans?Lippert Ferdinand?K?ckerling 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2012,397(2):283-289
Purpose
The use of a mesh with good biocompatibility properties is of decisive importance for the avoidance of recurrences and chronic pain in endoscopic hernia repair surgery. As we know from numerous experiments and clinical experience, large-pore, lightweight polypropylene meshes possess the best biocompatibility. However, large-pore meshes of different polymers may be used as well and might be an alternative solution. 相似文献82.
Matthew J. Budoff Sandy Liu David Chow Ferdinand Flores Brian Hsieh Dan Gebow Tony DeFrance Naser Ahmadi 《Atherosclerosis》2014
Background: Previous studies have shown that computed tomography coronary angiography (CTA) in patients with suspected coronary artery disease (CAD) predicts short term adverse events. However, there is no current data on whether identifying atherosclerosis on CTA impacts outcomes. We performed a case–control study to assess whether information from CTA can improve outcomes. Methods: 4244 symptomatic patients (mean age 58 ± 9, 62.5% male) without known CAD who underwent CTA (n = 2538) to rule out CAD were matched to 1706 patients who underwent standard of care in an academic cardiology clinic. Patients were propensity-matched by gender, age, ethnicity, CAD risk factors and follow-up duration. The primary outcome measure was all-cause mortality. Multivariable Cox proportional hazards models incorporated age, gender and traditional risk factors for coronary disease as well as pre-test probability of CAD. Results: There were no significant differences in age, gender, conventional risk factors between groups (p > 0.05). During a mean follow up of 80 ± 11 months, the overall death rate was 6.3% (270 deaths). Death rate was significantly lower in CTA group (n = 106, 4.2%) as compared to the control group (n = 184, 10.8%, p = 0.001). Event free survival was 95.8% and 89.2% in CTA and standard of care groups, respectively. Risk-adjusted hazard ratio of death were 2.5 (95%CI: 1.6–6.7, p = 0.003) in standard of care cohort as compared to CTA group. Multivariate analysis demonstrated that undergoing coronary CTA resulted in a risk reduction of 32%, p = 0·0001. Conclusions: Improved knowledge of atherosclerosis or increased anti-atherosclerotic therapies among those undergoing CTA may have contributed to improved survival. Our results provide evidence of potential benefit from scanning for atherosclerosis with CTA in symptomatic patients. Large randomized trials are warranted. 相似文献
83.
Neutel JM Saunders E Bakris GL Cushman WC Ferdinand KC Ofili EO Sowers JR Weber MA;INCLUSIVE Investigators 《Journal of clinical hypertension (Greenwich, Conn.)》2005,7(10):578-586
This multicenter, prospective, open-label, single-arm study determined the efficacy and safety of irbesartan/hydrochlorothiazide (HCTZ) fixed combinations in patients (n=1005), aged 18 years and older, with uncontrolled systolic blood pressure (SBP) of 140-159 mm Hg (130-159 mm Hg for type 2 diabetes mellitus) after at least 4 weeks of antihypertensive monotherapy. Treatment was sequential: placebo (4-5 weeks), HCTZ 12.5 mg (2 weeks), irbesartan/HCTZ 150/12.5 mg (8 weeks), and irbesartan/HCTZ 300/25 mg (8 weeks). Enrolled patients (n=844) were aged 57.3+/-11.2 years; 52% were women, 23% were African American, and 14% were Hispanic. Thirty percent had type 2 diabetes mellitus, 46% had metabolic syndrome, and baseline blood pressure was 154.0+/-10.3/91.3+/-8.8 mm Hg. The mean change in SBP from placebo end to the primary end point, Week 18 (intent-to-treat population, n=736) was -21.5+/-14.3 mm Hg (p<0.001). The mean change in diastolic blood pressure (DBP) was -10.4+/-8.7 mm Hg (p<0.001). The mean Week 18 SBP/DBP was 132.9+/-13.8/81.1+/-9.7 mm Hg. Overall, 77% (95% confidence interval, 74%-80%) of patients achieved SBP goal (<140 mm Hg; <130 mm Hg for type 2 diabetes mellitus); 83% (95% confidence interval, 80%-86%) achieved DBP goal (<90 mm Hg; <80 mm Hg for type 2 diabetes mellitus); and 69% (95% confidence interval, 66%-72%) achieved dual SBP/DBP goal. Treatments were well tolerated. This irbesartan/HCTZ treatment regimen achieved SBP goals in more than 75% of patients uncontrolled on monotherapy. 相似文献
84.
Matthew J Budoff Leslee J Shaw Sandy T Liu Steven R Weinstein Tristen P Mosler Philip H Tseng Ferdinand R Flores Tracy Q Callister Paolo Raggi Daniel S Berman 《Journal of the American College of Cardiology》2007,49(18):1860-1870
OBJECTIVES: The purpose of this study was to develop risk-adjusted multivariable models that include risk factors and coronary artery calcium (CAC) scores measured with electron-beam tomography in asymptomatic patients for the prediction of all-cause mortality. BACKGROUND: Several smaller studies have documented the efficacy of CAC testing for assessment of cardiovascular risk. Larger studies with longer follow-up will lend strength to the hypothesis that CAC testing will improve outcomes, cost-effectiveness, and safety of primary prevention efforts. METHODS: We used an observational outcome study of a cohort of 25,253 consecutive, asymptomatic individuals referred by their primary physician for CAC scanning to assess cardiovascular risk. Multivariable Cox proportional hazards models were developed to predict all-cause mortality. Risk-adjusted models incorporated traditional risk factors for coronary disease and CAC scores. RESULTS: The frequency of CAC scores was 44%, 14%, 20%, 13%, 6%, and 4% for scores of 0, 1 to 10, 11 to 100, 101 to 400, 401 to 1,000, and >1,000, respectively. During a mean follow-up of 6.8 +/- 3 years, the death rate was 2% (510 deaths). The CAC was an independent predictor of mortality in a multivariable model controlling for age, gender, ethnicity, and cardiac risk factors (model chi-square = 2,017, p < 0.0001). The addition of CAC to traditional risk factors increased the concordance index significantly (0.61 for risk factors vs. 0.81 for the CAC score, p < 0.0001). Risk-adjusted relative risk ratios for CAC were 2.2-, 4.5-, 6.4-, 9.2-, 10.4-, and 12.5-fold for scores of 11 to 100, 101 to 299, 300 to 399, 400 to 699, 700 to 999, and >1,000, respectively (p < 0.0001), when compared with a score of 0. Ten-year survival (after adjustment for risk factors, including age) was 99.4% for a CAC score of 0 and worsened to 87.8% for a score of >1,000 (p < 0.0001). CONCLUSIONS: This large observational data series shows that CAC provides independent incremental information in addition to traditional risk factors in the prediction of all-cause mortality. 相似文献
85.
86.
Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment 总被引:3,自引:1,他引:3
Abstract: The effects of immediate-release melatonin on circadian rest-activity profiles, cognition, and mood were investigated in ten elderly individuals with self-reported sleep-wake disturbances. Melatonin (6 mg), administered 2 hr before habitual bedtime, enhanced the rest-activity rhythm and improved sleep quality as observed in a reduction in sleep onset latency and in the number of transitions from sleep to wakefulness. However, total sleep time was not significantly increased nor was wake within sleep significantly reduced. The ability to remember previously learned items improved along with a significant reduction in depressed moods. No side effects or contraindications were reported by any of our participants during the 10 day trials. These data suggest that melatonin can safely improve some aspects of sleep, memory, and mood in the elderly in short-term use. 相似文献
87.
88.
89.
90.
The goal of the present study was to demonstrate that declarative and non-declarative knowledge acquired in an incidental sequence learning task contributes differentially to memory retrieval and leads to dissociable ERP signatures in a recognition memory task. For this purpose, participants performed a sequence learning task and were classified as verbalizers, partial verbalizers, or nonverbalizers according to their ability to verbally report the systematic response sequence. Thereafter, ERPs were recorded in a recognition memory task time-locked to sequence triplets that were either part of the previously learned sequence or not. Although all three groups executed old sequence triplets faster than new triplets in the recognition memory task, qualitatively distinct ERP patterns were found for participants with and without reportable knowledge. Verbalizers and, to a lesser extent, partial verbalizers showed an ERP correlate of recollection for parts of the incidentally learned sequence. In contrast, nonverbalizers showed a different ERP effect with a reverse polarity that might reflect priming. This indicates that an ensemble of qualitatively different processes is at work when declarative and non-declarative sequence knowledge is retrieved. By this, our findings favor a multiple-systems view postulating that explicit and implicit learning are supported by different and functionally independent systems. 相似文献